Foundayo
-
{
- All
- News
-
Eli Lilly's New Oral GLP-1 Orforglipron Beats Semaglutide In Diabetes Trials; FDA Filing Near
- Wednesday June 10, 2026
- Health | Written by Varsha Vats
Foundayo was incredibly effective at lowering A1C, which is a metric doctors use to measure average blood sugar levels over a 2 to 3-month period.
-
www.ndtv.com/health
-
FDA Approves New Weight-Loss Pill For Use At Any Time Of Day
- Thursday April 2, 2026
- Science | Edited by Nikhil Pandey
The US regulator has approved Eli Lilly's new oral weight-loss drug Foundayo through a fast-track process, offering a more convenient and potentially affordable alternative to injectable obesity treatments.
-
www.ndtv.com
-
Lilly Wins Approval For New Weight Loss Pill Foundayo — Features, Price, Availability Explained
- Thursday April 2, 2026
- Author: NDTV Profit News, Edited by: Shrikant Shankar
Eli Lilly stated that Foundayo is designed to aid weight loss and maintenance when "used alongside a reduced-calorie diet and increased physical activity."
-
www.ndtvprofit.com
-
Eli Lilly's New Oral GLP-1 Orforglipron Beats Semaglutide In Diabetes Trials; FDA Filing Near
- Wednesday June 10, 2026
- Health | Written by Varsha Vats
Foundayo was incredibly effective at lowering A1C, which is a metric doctors use to measure average blood sugar levels over a 2 to 3-month period.
-
www.ndtv.com/health
-
FDA Approves New Weight-Loss Pill For Use At Any Time Of Day
- Thursday April 2, 2026
- Science | Edited by Nikhil Pandey
The US regulator has approved Eli Lilly's new oral weight-loss drug Foundayo through a fast-track process, offering a more convenient and potentially affordable alternative to injectable obesity treatments.
-
www.ndtv.com
-
Lilly Wins Approval For New Weight Loss Pill Foundayo — Features, Price, Availability Explained
- Thursday April 2, 2026
- Author: NDTV Profit News, Edited by: Shrikant Shankar
Eli Lilly stated that Foundayo is designed to aid weight loss and maintenance when "used alongside a reduced-calorie diet and increased physical activity."
-
www.ndtvprofit.com